Home > Insider Trading > Filing (0001666071-21-000115)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1666071	Cardlytics Inc.	CDLX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1181211	V John Balen	C/O Cardlytics, Inc. 675 Ponce De Leon Avenue Ne, 6000 Atlanta GA 30308		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-05-14	1,000	$91.57	25,074	No	4	P	Direct
Common Stock	Acquisiton	2021-05-14	1,000	$92.92	26,074	No	4	P	Direct
Common Stock	Acquisiton	2021-05-25	1,000	$103.11	27,074	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2021-05-21	1,701	$0.00	1,701	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,701			No	4	A	Direct

Footnotes

The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $91.565 to $91.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.
The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $92.8863 to $92.98, inclusive.
The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $102.68 to $103.43, inclusive.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date.